Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Selected investments

    Country Date Notes
    aTyr Pharma Inc
    United States 1 Apr 2007
    1 Oct 2010
    Series C
    Active
    Sirtris Pharmaceuticals Inc
    United States 1 Dec 2004
    1 Mar 2005
    19 Apr 2006
    Series C
    Active
    Verastem Inc
    United States N/A
    CodeRyte Inc
    Natural Language Processing for computer-assisted coding of medical dictation notes for medical billing.
    United States N/A
    Initial investment. Round participant. Active
    AccentCare Inc
    Skilled Nursing Services, Private-duty home care services.
    United States N/A
    Active
    Axogen Inc
    Developmer of treatment options for the repair of peripheral nerve injuries.
    United States N/A
    Active
    SironaHealth
    Providing telehealth, call center, and technology solutions to healthcare organizations across the United States.
    N/A
    Cubist Pharmaceuticals Inc
    Cubist Pharmaceuticals is a bio-pharmaceutical company.
    N/A
    Active
    Bioconnect Systems Inc
    Bioconnect Systems, Inc. is pioneering novel surgical implants and techniques that form precisely controlled vascular connections.
    United States N/A
    TechRx Inc
    Software for automating the pharmaceutical distribution supply chain.
    N/A
    Abide Therapeutics Inc
    Abide Therapeutics, Inc. will exploit the vast therapeutic potential of serine hydrolases.
    United States N/A
    Active
    FluidNet Inc
    Revolutionary infusion pump technology based on pneumatics rather than mechanics.
    N/A
    NexCura Inc
    United States N/A
    Alnylam Pharmaceuticals Inc
    United States N/A
    Replication Medical Inc
    Replication Medical develops and manufactures a broad portfolio of implantable medical devices based on its proprietary hydrogel platform technology.
    United States N/A
    Teladoc Inc
    United States N/A
    Momenta Pharmaceuticals Inc
    Momenta is a leader in the analysis, characterization, and design of complex pharmaceutical products.
    N/A

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.